Academic Liver Debates
Northeast Ohio Academic Liver Debates 2022
The Northeast Ohio community hosted debates in 2018 and 2019. Due to COVID-19 and the Delta Variance, there was no debate in 2020 nor 2021. We are excited to have the debates returning in December 2022 as Northeast Ohio – Academic Liver Debates, a program of the Northeast Ohio Liver Alliance.
This year’s Northeast Ohio Academic Liver Debates builds off the success of previous debates. Debate teams will be assigned topics, work with mentors, and be judged by a panel of physicians. This program is offered free of charge to attend with a suggested Donation of $25
Date: Wednesday, October 19, 2022
Time: 5:30pm-9pm
Location: Intercontinental Hotels Cleveland, 9801 Carnegie Avenue, Cleveland, Ohio 44106-2100
Cost: Free to attend with a suggested Donation of $25
MODERATOR
Dr. Gautham Reddy
University of Chicago
TOPICS & TEAMS
Debate #1: IR therapy vs. Systemic therapy for multifocal HCC confined to the liver
Pro: He should be referred to interventional radiology
(IR) for therapy such as chemoembolization or Y 90 radiotherapy.
Mentor: Seth Sclair, MD
Fellows: Dr. Fangyuan Jin-Dominguez and Dr. Dayyan Mohammed Adoor
Con: He should be referred to medical oncology for systemic
therapy such as atezolizumab/bevacizumab.
Mentor: Kim Brown, MD
Fellows: Dr. Kevin Harris and Dr. Muhammad Zarrar Khan
Debate #2: TIPS for variceal bleeding
Pro: He should undergo TIPS now for secondary variceal
bleeding prophylaxis.
Mentor: Bolin Niu, MD
Fellows: Dr. Shaman Dalal and Dr. Nahel Tunio
Con: He should undergo endoscopic variceal band ligation
until obliteration and non-selective beta-blocker for secondary variceal bleeding prophylaxis.
Mentor: Christina Lindenmeyer, MD
Fellows: Dr. Indira Bhavsar-Burke and Dr. Mahnur Haider
JUDGES
Dr. Fady Haddad
Dr. Farid Naffah
Dr. Gautham Reddy
Dr. Mousab Tabbaa
The Audience Has One Vote
Date: Wednesday, October 19, 2022
Time: Registration and Reception is 5:30pm-6:30pm; Dinner and Debates 6:30pm-9:00pm
Location: Intercontinental Hotels Cleveland, 9801 Carnegie Avenue, Cleveland, Ohio 44106-2100
Cost: Free to attend with a suggested Donation of $25
Topics
- Debate #1: IR therapy vs. Systemic therapy for multifocal HCC confined to the liver
- Pro: He should be referred to interventional radiology (IR) for therapy such as chemoembolization or Y 90 radiotherapy.
- Con: He should be referred to medical oncology for systemic therapy such as atezolizumab/bevacizumab.
- Debate #2: TIPS for variceal bleeding
- Pro: He should undergo TIPS now for secondary variceal bleeding prophylaxis.
- Con: He should undergo endoscopic variceal band ligation until obliteration and non-selective beta-blocker for secondary variceal bleeding prophylaxis.
2022 Highlights
2022 Debaters, Mentors, Moderator and Judges
2022 Debate Topics and Winners
Debate #1: IR therapy vs. Systemic therapy for multifocal HCC confined to the liver
University Hospitals – 1st Place
Debated the Pro Position: Patient should be referred to interventional radiology (IR) for therapy such as chemoembolization or Y 90 radiotherapy.
Picture (L to R): Dr. Dayyan Mohammed Adoor (Fellow), Seth Sclair, MD (Mentor) and Dr. Fangyuan Jin-Dominguez (Fellow)
Henry Ford Health – 2nd Place
Debated the Con Position: Patient should be referred to medical oncology for systemic therapy such as atezolizumab/bevacizumab.
Picture (L to R): Dr. Deepak Venkat (Mentor), Dr. Kevin Harris (Fellow), Dr. Yasmine Hussein Agha (Fellow) and Dr. Reena Salgia (Mentor)
Debate #2: TIPS for variceal bleeding
Cleveland Clinic – 1st Place
Debated the Con Position: Patient should undergo endoscopic variceal band ligation until obliteration and non-selective beta-blocker for secondary variceal bleeding prophylaxis.
Picture (L to R): Dr. Indira Bhavsar-Burke (Fellow), Christina Lindenmeyer, MD (Mentor) and Dr. Mahnur Haider (Fellow)
MetroHealth – 2nd Place
Debated the Pro Position: He should undergo TIPS now for secondary variceal bleeding prophylaxis.
Picture (L to R): Dr. Nahel Tunio (Fellow), Dr. Bolin Niu (Mentor) and Dr. Shaman Dalal (Fellow)
